2024 ATLS Global Symposium

The Advanced Trauma Life Support (ATLS) Global Symposium will be held on Friday and Saturday, March 8–9, 2024, in conjunction with the COT Annual Meeting in Chicago. Join us for an outstanding educational program and the chance to network with ATLS course directors, site coordinators, instructors, and educators from around the world. 

High-Level Schedule

Please refer to the high-level schedule below when planning your travel and booking hotel reservation.

Friday, March 8, 2024

7:00 am-12:00 pm: SEAB Workgroup Meeting (by invitation only)
7:00 am-12:00 pm: ATLS 11 Revision Site Coordinators Workgroup Meeting (by invitation only)
12:30-2:00 pm: Networking Lunch (All Global Symposium Attendees)
2:00-5:00 pm: Global Symposium Launch: All there is to know about the ATLS 11th Revision - Join the ATLS 11 revision steering committee, educators, coordinators and ACS staff for content updates and the timeline for launching ATLS 11th revision, myATLS app, Instructor courses, and more!

Saturday, March 9, 2024

All Day (8:00 am-5:00 pm): “Pop-up” Room: Come meet the ACS Trauma Education customer service team. Representatives of the team will be available to meet 1-on-1 or in small groups. Come with questions, ideas, and to network with colleagues.
7:00-9:00 am: Networking Breakfast
7:45-8:45 am: STOP THE BLEED3 Instructor Training
9:00 am-12:00 pm: Trauma Education Around the World - Come learn from ATLS Colleagues around the world on best practices and innovations in ATLS. Speakers will be a diverse group representing different regions and various ATLS roles. 
12:00-1:00 pm: Lunch, Awards, and Anniversary Recognitions
1:15-2:45 pm: Breakout Sessions (select from a number of accepted peer-reviewed proposals and learn from your Trauma Education colleagues).
3:00-5:00 pm: Plenary Session - Join a moderated panel session including prominent individuals from the ATLS community. Best practices and innovations will be shared on a wide range of relevant topics. All in attendance will also be asked to participate using an audience response system. This will also include final remarks and adjourn the education program of the Global Symposium. 
5:00-6:00 pm: Networking Reception

Sunday, March 10, 2024

9:00 am-12:00 pm: ATLS 11 Revision Work Groups Post-Conference Meeting (by invitation only)

Invited attendees will receive a private invitation to confirm attendance. This meeting will not be at the Hilton hotel but at another location).

____________________________________________________________________________________________________________________

ATLS Global Symposium Attendees are invited to participate in the following COT 2024 Annual Meeting sessions and events:

Thursday, March 7, 2024

1:00-6:00 pm: Resident and Fellow Trauma Paper Competition
6:00-7:00 pm: Networking Reception

Friday, March 8, 2024

7:00-8:15 am: Regions 9-17 Breakfast Committee Meetings
6:30-10:00 pm:  COT Member Cocktail Reception & Banquet (Ticketed Event)

The schedule is subject to change. All times listed in Central Time.

Target Audience

  • ATLS Faculty
  • ATLS Course Directors
  • ATLS Site Coordinators
  • ATLS Educators
  • Any clinician involved in ATLS or other Trauma Education Courses

Learning Objectives

  • Discuss new research in patient care for trauma injuries. 
  • Evaluate new methods for treatment of trauma patients. 
  • Network and collaborate with other trauma healthcare providers.
  • Recognize how to apply new knowledge and skills gained at home institution. 
Course summary
Available credit: 
  • 10.00 AMA PRA Category 1 Credit™
  • 10.00 CE Contact hours
  • 10.00 Certificate of Completion
Course opens: 
03/09/2024
Course expires: 
05/10/2024
Rating: 
4

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible Company:   The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Disclosure List: 

 

Speakers / Moderators / Discussants/Authors

Nothing to Disclose

Disclosure

Company

Role

Received

Andrew Baker, MBChB

 

Smith & Nephew

Design Consultant

Honorarium

Jeffrey Kerby, MD, FACS

X

 

 

 

Eileen Bulger, MD, FACS

X

 

 

 

Andre Das, FRCS

X

 

 

 

David King, MD

 

Polynovo

N/A

Passive Stocks

Warren Rorald, MD, MHPED, FPCS, FACS

X

 

 

 

Saud Al-Turki, MD

X

 

 

 

Samy Bendjemil, MD, MPH

X

 

 

 

Felix Ramirez Ibarra, MD, FACS

X

 

 

 

Elizabeth de Solezio, MD, FACS

X

 

 

 

Vicente Rodriguez, MD, FACS

X

 

 

 

Samir Ballouz, MSc, IHM

X

 

 

 

Claire Leidy

X

 

 

 

John Agapian, MD, FACS, FCCM

X

 

 

 

Galinos Barmparas, MD

X

 

 

 

Susan Briggs, MD, MPH, FACS

X

 

 

 

Jeanette Capella, MD, MEd, FACS

X

 

 

 

Michael Person, MD, MPH, FACS

X

 

 

 

Mayur Narayan, MD, MPH, MBA, MHPE, FACS, FCCM, FICS, FACT, FAIM 

 

Medcura, Inc.

Advisor

Stocks

Al Sherwin Martin

X

 

 

 

Selmy Awad, MD, MRCS

X

 

 

 

Waleed Althobaiti

X

 

 

 

Nicholas Galouzis, MD, MBA

X

 

 

 

Haroon Majid, FRCS

X

 

 

 

Robert Vezetti, MD, FAAP, FACEP

X

 

 

 

Ada Earp, DO, FAAP, CHSE

X

 

 

 

Vicente Cardona-Infante, MD, FACS

X

 

 

 

Mary Stuever, DO, FACS

X

 

 

 

Raymond Fang, MD, FACS

X

 

 

 

Thomas Duncan, DO, FACS

X

 

 

 

Jenna Faulkner, RN

X

 

 

 

Abdelhakim Elkholy, MD

X

 

 

 

Nirav Patel, MD, FACS

X

 

 

 

Deborah Paltridge

X

 

 

 

Elizabeth McAllister

X

 

 

 

Brandon Schawel, MA

X

 

 

 

Julie Cwik, MSEd, MSLIS

X

 

 

 

Olivia Grierson

X

 

 

 

Meghan Hogan, PhD

X

 

 

 

Neil Kato

X

 

 

 

Ana Hernandez

X

 

 

 

Margaret (Meghan) Baker

X

 

 

 

Planning Committee

Nothing to Disclose

Disclosure

Company

Role

Received

Kimberly Joseph, MD, FACS

X

 

 

 

John Sutyak, MD, FACS

X

 

 

 

Dany Westerband, MD, FACS

X

 

 

 

George Abi-Saad, MD, FACS

X

 

 

 

Sharon Henry, MD, FACS

X

 

 

 

Scott D’Amours, MD, FACS

X

 

 

 

Cathy Wilson, MD, FACS

X

 

 

 

Joakim Jorgensen, MD, FACS

X

 

 

 

Alisa Nagler, JD, MA, EdD

X

 

 

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.

Provider approved by the California Board of Registered Nursing, Provider Number CEP 17399 for 10.0 contact hours.

Available Credit

  • 10.00 AMA PRA Category 1 Credit™
  • 10.00 CE Contact hours
  • 10.00 Certificate of Completion
Please login or register to take this course.